Tag: pharmaceuticals
-
Trial to Test Gene Therapy for Inherited Eye Disease
A spin-off enterprise from University of Oxford in the U.K. began enrolling participants in a clinical trial testing gene therapy to correct a genetic eye disease.
-
Organ Transplant Start-Up Gains $38M in Early Funds
A one year-old company applying genome editing to make animal organs fit for human transplantation is raising $38 million its first venture funding round.
-
Simpler Method Devised to Produce Malaria Drug
A biochemistry group in the U.K. developed simpler and potentially more efficient techniques for producing a first-line drug for treating malaria.
-
Allergan to Option Gene Editing for Eye Diseases
International drug maker Allergan is gaining access to treatments for inherited eye diseases being developed by Editas Medicine, a spin-off enterprise from MIT and Harvard.
-
Trial Shows Bioactive Glass Stops Bone Infections
Grafts of glass-based substitute material were shown in a clinical trial to stop bacterial bone infections from osteomyelitis, in most cases without additional antibiotics.
-
Nanotech Gel Designed to Treat Snake Bites
A team from University of California in Irvine developed a snake bite treatment that in lab tests stops venom more effectively and at lower cost than current antidotes.
-
Precision Medicine, “My Hope for the Future”
A meeting on Capitol Hill in Washington, D.C. today heard about one person’s struggle with cystic fibrosis and her hope for precision medicine to provide a cure.
-
Trial Underway to Test Cancer Immunotherapy Aid
A clinical trial began recruiting participants with advanced tumors to test a compound that helps treatments for cancer harnessing the immune system.
-
Messenger RNA Engineered to Produce Antibodies
Academic and industry researchers demonstrated production of therapeutic antibodies inside cells of lab mice, offering a simpler and lower-cost alternative to monoclonal antibodies.
-
Biotech Companies to Discover Ebola, Zika Vaccines
Two biotechnology companies are collaborating to discover new vaccines protecting against Ebola and Zika viruses that present global threats to public health.